Results 91 to 100 of about 1,334 (146)

Antibody-based therapeutics and therapeutic development for diabetic retinopathy: targeting VEGF, Ang/Tie, and inflammatory pathways. [PDF]

Front Endocrinol (Lausanne)
Zong Y, Qiu S, Zhang H, Wu J, Du J, Kamoi K, Cen Z.   +6 more
europepmc   +1 more source

Flexible Loading Phase Treat-and-Extend Regimen with Faricimab for Neovascular Age-Related Macular Degeneration: A Real-World Study. [PDF]

Biomedicines
Machida A, Kurihara J, Hirata Y, Machida E, Murakami R, Oka A, Yoneda A, Tsuiki E, Oishi A.   +8 more
europepmc   +1 more source

Progress in the treatment of diabetic macular edema with faricimab: a review. [PDF]

Front Med (Lausanne)
Gao M, Liu C, Zeng Y, Wu X, Duan J.
europepmc   +1 more source

One year outcomes of intravitreal faricimab for treatment Naïve neovascular AMD and associations with baseline aqueous humor cytokines. [PDF]

Sci Rep
Inoda S, Takahashi H, Hashimoto Y, Yoshida H, Takahashi H, Takayama T, Tsuchiya S, Matsumoto D, Kawashima H, Kaburaki T, Yanagi Y.   +10 more
europepmc   +1 more source

Faricimab for Refractory Neovascular Age-Related Macular Degeneration: Retrospective Real-World Evidence from India. [PDF]

Clin Ophthalmol
Biswas RK, Sheth JU, Shrivastava V, Kaur J, Sinha S, Pal SS, Nandi K, Das S.   +7 more
europepmc   +1 more source

One-year clinical outcomes of four-dose induction versus immediate treat-and-extend faricimab regimens in pretreated neovascular age-related macular degeneration. [PDF]

BMC Ophthalmol
Menghini M, Grimaldi G, Paris A, Bachmann LM, Schmid MK.   +4 more
europepmc   +1 more source

Efficacy and Safety of Intravitreal Faricimab in Age-Related Macular Degeneration-A Review. [PDF]

J Clin Med
Chan CC, Liu PK, Cheng KC, Lai HC, Chang YC.   +4 more
europepmc   +1 more source

A Pilot Study on Structural Changes of Choroidal Vasculature Following Intravitreal Anti-VEGF Injection in Neovascular Age-Related Macular Degeneration: Faricimab vs Ranibizumab. [PDF]

J Clin Med
Nishiyama T, Hirai H, Miyata K, Nishi T, Ueda T, Kase S.   +5 more
europepmc   +1 more source

Does the Efficacy, Durability, and Safety of Faricimab for Diabetic Macular Edema in Randomized Trials Translate into Real-World Settings? [PDF]

Ophthalmol Ther
Peto T, Vujosevic S, Sheth V, Downey A, Gibson K, Pollreisz A.   +5 more
europepmc   +1 more source